Fig. 1: SH3PXD2A-AS1 is upregulated in NSCLC tumour tissues.

A Kaplan–Meier survival curve analysis was performed to explore the effects of the genes on the survival rate in LUAD (Left, P < 0.01) and NSCLC (Right, P < 0.05). B SH3PXD2A-AS1 expression was analysed in LUAD or LUSC tissues and normal tissues in the GEPIA database. C SH3PXD2A-AS1 expression was validated in 14 pairs of NSCLC patient samples by qRT-PCR. Lnc2(SH3PXD2A-AS1). Data are shown as the mean ± standard deviation from three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001.